Dr. Lianne K. Cavell, MD

Dr. Cavell practices at Outpatient Center of Delray in Delray Beach, Florida.

Dr. Cavell's NPI, 1215194758, was assigned on May 21, 2008. Dr. Cavell graduated from Albert Einstein College of Medicine in 2007. Dr. Cavell holds Florida license ME115795.

Dr. Cavell's primary practice is Outpatient Center of Delray, at 4675 W Linton Blvd, Delray Beach, FL 33445 in Palm Beach County. The practice phone is (561) 499-9585.

Dr. Cavell's primary practice is Outpatient Center of Delray in Delray Beach, Florida. The medical group on file is Gastro Health. Dmand AI also links Dr. Cavell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cavell practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Cavell's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Cavell is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Cavell's licenses on file in 2 states: Florida and New York.

Dmand AI lists acid reflux, acute gallbladder or bile duct inflammation, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy and fatty liver among the conditions Dr. Cavell treats.

CMS data shows 31,052 Medicare services from Dr. Cavell across 21 procedure codes in 2024, for 821 Medicare patients. Medicare paid $678,531 for them.

CMS counts 821 Medicare patients who saw Dr. Cavell in 2024. The largest group is 65 to 74, with 388 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cavell's median patient age at 63, with 69% women.

In 2024, Dr. Cavell wrote 1,017 Medicare Part D claims for 434 patients. 67% of them were for generic drugs. CMS names the drug for 850 of them, across 21 drugs with 11 or more claims each, at $862,643 in total drug cost. In 2023, CMS named 811 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Cavell for performance year 2024, reported as part of a group.

Dmand AI links 1 paper to Dr. Cavell in 2013. Dr. Cavell's most frequent co-authors are Peter J. Allen, MD, Michael I. D'Angelica, MD and Ronald P. Dematteo, MD.

CMS Open Payments shows 476 general payments to Dr. Cavell from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $2,018.

Dr. Cavell graduated from Albert Einstein College of Medicine in 2007.

Dr. Cavell is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.